Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|July 20, 2004
A conserved sequence in the mouse variable T cell receptor alpha recombination signal sequence 23-bp spacer can affect recombinationJochen Probst, Sibylle G Blumenthal, Stefan Tenzer, et al.
European Journal of Immunology|February 10, 2004
Immunostimulating capacities of stabilized RNA moleculesBirgit Scheel, Sybilla Braedel, Jochen Probst, et al.
Nutrients|September 28, 2021
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical TrialAndreas Pinter, Peter Schwarz, Sascha Gerdes, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 13, 2005
Co-transfection of messenger RNA and siRNA as a method to study the efficiency of siRNAThorsten Mutzke, Gudrun Schubkegel, Regina Teufel, et al.
Nature Biotechnology|November 20, 2012
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infectionBenjamin Petsch, Margit Schnee, Annette B Vogel, et al.
International Journal of Cancer|December 23, 2014
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profileRegina Heidenreich, Edith Jasny, Aleksandra Kowalczyk, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
RNA Biology|June 10, 2011
Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathwayChristina Lorenz, Mariola Fotin-Mleczek, Günter Roth, et al.
European Journal of Immunology|April 16, 2005
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNABirgit Scheel, Regina Teufel, Jochen Probst, et al.
International Immunology|December 30, 2004
The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cellsSteve Pascolo, Florent Ginhoux, Nihay Laham, et al.
Pageof 3